Background: Ureteric stents are used to prevent urological complications like ureteric fistulas and obstruction in kidney transplants. Despite its advantages, complications arising from delayed removal of a double J (DJ) stent include urinary tract infections, stone encrustation, and migration of the DJ stent [Sansalone et al.: Transplant Proc 2005;37:2511-2515]. Encrustation of the stent makes removal difficult and risks injury to the transplanted kidney. Case Presentation: We report a case of retained DJ stent for 19 years presenting with recurrent urinary tract infections. A radiograph revealed a retained ureteric stent extending from the right iliac fossa transplant kidney to the urinary bladder with multiple foci of large calcification along its length. Two sessions of extracorporeal shockwave lithotripsy along the stent were performed after a percutaneous nephrostomy tube had been placed in the transplanted kidney. Subsequently, the retained DJ stent was removed endoscopically after laser lithotripsy to remnant calcifications. Remnant stone fragments were removed with another session of ureteroscopy and laser lithotripsy. The patient achieved complete stent and stone clearance with a functioning graft. Conclusion: This case illustrates that significant stone encrustation of the retained stent in a transplanted kidney can be treated successfully with a combination of endourological techniques.

Keywords:
Forgotten stent, Renal transplantation, Endourological techniques
1.
Andrés A: Indications and contraindications of living donor kidney transplantation (in Spanish). Nefrologia 2010;30(suppl 2):30-38.
2.
Rajaian S, Kumar S: There is no need to stent the ureterovesical anastomosis in live renal transplants. Indian J Urol 2010;26:454-456.
3.
Minnee RC, Surachno S, Kox C, ten Berge IJ, Aronson DC, Idu MM: Is a selective splinted ureterocystostomy protocol feasible in renal transplantation. An analysis of 475 renal transplantations? Transpl Int 2006;19:558-562.
4.
Blanchet P, Hammoudi Y, Eschwege P, Droupy S, Bensadoun H, Hiesse C, et al: Urinary complications after kidney transplantation can be reduced. Transplant Proc 2000;32:2769.
5.
Sansalone CV, Malone G, Aseni P, Mangoni I, Soldano S, Minetti E, et al: Advantages of short time ureteric stenting for the prevention of urological complications in kidney transplantation: an 18-year experience. Transplant Proc 2005;37:2511-2515.
6.
Mangus RS, Haag BW: Stented versus nonstented extravesical utereroneocystostomy in renal transplantation: a metaanalysis. Am J Transplant 2004;4:1889-1896.
7.
Gallego D, Persiva JB, Mestre MP, Martin IJP, Aguado JM, Perello CM, Argente VG, Sanz MB, De Francia Valero JA: Double J catheter migrated to the bladder and encrusted. Case report and bibliographic review. Arch Esp Urol 2012;65:251-255.
8.
Sengottayan VK, Vasudeva P, Goel A, Dalela D: Incontinence due to fragmentation of forgotten ureteral stent: an unusual complication. Urology 2009;74:1230-1231.
9.
Lee SW, Kim JH: Renocolic fistula secondary to a perinephric abscess: a late complication of a forgotten double J stent. J Korean Med Sci 2009;24:960-962.
10.
Giustacchini M, Tazza L, Raguso M, Albino G: Ureteral stent forgotten in renal transplanted patient. Its removal. Arch Ital Urol Androl 1999;71:223-224.
11.
Bhuva S, Kennish SJ, Wah TM: Forgotten indwelling stent in a transplanted kidney: a case report. Cases J 2009;2:27.
12.
Veltman Y, Shields JM, Ciancio G, Bird VG: Percutaneous nephrolithotomy and cystolithalapaxy for a ‘forgotten' stent in a transplant kidney: case report and literature review. Clin Transplant 2010;24:112-117.
13.
Henderson A, Gujral S, Mitchelmore AE, Keeley FX Jr: Endo-urological techniques in the management of stent complications in the renal transplant patient. Transpl Int 2002;15:664-666.
14.
Yenicesu M, Aydur E, Yildirim I, Yenicesu F, Seckin B: A long-forgotten indwelling ureteral stent in a renal transplant patient. Transplant Proc 2004;36:1395-1397.
15.
Gedroyc WM, MacIver D, Joyce MR, Saxton HM: Percutaneous stone and stent removal from renal transplants. Clin Radiol 1989;40:174-177.
16.
Romanowsky I, Lupu L, Lismer L, Babaev L, Neulander EZ, Kaneti J: Percutaneous nephrolithotomy in transplanted kidney - forgotten stent with complete staghorn and large bladder stone. Case report. Transpl Int 2005;17:877-879.
17.
de la Rosette JJ, Zuazu JR, Tsakiris P, Elsakka AM, Zudaire JJ, Laguna MP, et al: Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the Clavien classification. J Urol 2008;180:2489-2493.
18.
Rhoderick TM, Yang HC, Escobar FS, Belis JA, Gifford RR: Extracorporeal shock wave lithotripsy in the renal transplant patient: a case report and review of literature. Clin Transplant 1992;6:375-378.
19.
Wilson CH, Bhatti AA, Rix DA, Manas DM: Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2005;4:CD004925.
20.
Alberts VP, Minnee RC, Bemelman FJ, van Donselaar-van der Pant KA, Laguna Pes P, Idu MM: Ureteral reconstruction after renal transplantation: clinical outcome and risk factors. Urol Int 2012;88:333-337.
21.
Kawahara T, Ito H, Terao H, Yoshida M, Ogawa T, Uemura H, Kubota Y, Matsuzaki J: Choosing an appropriate length of loop type ureteral stent using direct ureteral length measurement. Urol Int 2012;88:48-53.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.